Table 3 Relationship between galectin-3 levels and aortic calcification.
From: Mediating effect of vascular calcification in galectin-3-related mortality in hemodialysis patients
Vascular calcification (AoAC ≥ 1) | ||||
|---|---|---|---|---|
Univariate analysis | Multivariate analysis | |||
OR (95% CI) | p | OR (95% CI) | p | |
Age | 1.10 (1.07–1.12) | < 0.001 | 1.09 (1.06–1.12) | < 0.001 |
Sex, male | 1.76 (1.21–2.58) | 0.003 | 1.34 (0.78–2.30) | 0.289 |
CAD, history | 2.55 (1.56–4.18) | < 0.001 | 1.88 (0.97–3.65) | 0.061 |
Diabetes | 1.22 (0.84–1.78) | 0.285 | – | – |
Calcium, mg/dL | 1.03 (0.84–1.26) | 0.777 | – | – |
Phosphate ≥ 5.0 mg/dL | 0.81 (0.56–1.16) | 0.255 | – | – |
Albumin < 3.5 g/dL | 1.17 (0.79–1.73) | 0.416 | – | – |
hsCRP ≥ 1.0 mg/L | 1.63 (1.04–2.56) | 0.033 | 1.09 (0.64–1.86) | 0.746 |
HDL-C, mg/dL | 0.99 (0.98–1.01) | 0.706 | – | – |
Galectin-3 ≥ 37 ng/mL | 2.06 (1.41–3.02) | < 0.001 | 1.99 (1.15–3.42) | 0.013 |
